Initially, not all salivary glands were thought to be impaired while those glands that demonstrated damage seemed to heal spontaneously without further subjective and objective symptomatology.
Ainos plans to commence a site initiation visit for the study around April 2025, subject to regulatory approvals. The study aims to further assess the potential of VELDONA in improving salivary gland ...
Nipocalimab was granted U.S. FDA Breakthrough Therapy Designation for the treatment of adults living with moderate-to-severe Sjögren's disease based on results from the Phase 2 DAHLIAS study ...